Results 71 to 80 of about 31,464 (255)

Enhancing sustainability: The impact of ESG factors in global insurance performance

Borsa Istanbul Review
Sustainability has become a critical concern in finance, in particular for the insurance industry, which faces rising environmental and social risks.
Hasan Meral, Behlul Ersoy, Mesut Dogan
doaj   +1 more source

Non‐melanoma skin cancer risk with Janus kinase inhibitors compared to interleukin‐6 receptor inhibitors in rheumatoid arthritis: results from a national cohort study

Arthritis &Rheumatology, Accepted Article.
Background Non‐melanoma skin cancer (NMSC) is one of the most common malignancies in rheumatoid arthritis (RA). This analysis assessed NMSC risk with Janus kinase inhibitors (JAKi) compared to interleukin‐6 receptor inhibitors (IL‐6Ri). Method This study used data from the British Society for Rheumatology Rheumatoid Arthritis Register (BSRBR‐RA) linked
Zixing Tian, Lianne Kearsley‐Fleet, Sizheng Steven Zhao, James Galloway, Mark Lunt, Kath Watson, Narges Azadbakht, BSRBR‐RA Contributors Group, Kimme L Hyrich   +8 more
wiley   +1 more source

INFLUENCE OF NON-LIFE INSURANCE SECTOR CLAIMS SETTLEMENT ON THE INCREASE OF TOTAL ASSETS IN NIGERIA'S INSURANCE MARKET (2000 TO 2022)

International Studies Journal
The study looked at the influence of non-life insurance sector claims settlement on the increase of total assets in Nigeria's insurance market from 2000 to 2022.
SOLOMON DAVID PERE, JOSIAH BOLOU-OWEI EDIKE   +1 more
doaj  

Stochastic Frontier Estimation of Technical Efficiency Measurement in the Iranian Insurance Companies [PDF]

فصلنامه پژوهش‌های اقتصادی ایران, 2004
The main objective in this paper is twofold: measuring technical efficiency and indicating its determinant factors for the Iranian insurance companies.
Khosrow Piraee,, Hosein Kazemi
doaj  

Forecasting performance of Indian non-life insurance industry - an analysis of underwriting experience of public and private insurance companies

Asian Journal of Empirical Research, 2017
This paper is an initial attempt towards the direction of analysis of performances of Indian public and private non-life insurance companies and towards forecasting of future growth potential of the sector. This paper also presents future prospects and growth potentiality of the non-life insurance sector in India along with the current state of the ...
Subhabaha Pal, Kaushik Bhattacharjee, Satyabrata Pal   +2 more
openaire   +1 more source

Departing from standard practices: Strategic application of value engineering in the anatomy laboratory to enhance formaldehyde extraction using high‐impact, low‐cost, and low‐maintenance solutions

Anatomical Sciences Education, Volume 18, Issue 3, Page 241-253, March 2025.
Abstract This study describes the process of developing a high‐impact, low‐cost, and low‐maintenance air ventilation system for anatomy facilities. It employed the strategic application of Value Engineering (VE), assuring that the air ventilation system meets contemporary threshold limit values (TLVs) for formaldehyde in the working zone of dissection ...
Jürgen Russ, Niels Hammer
wiley   +1 more source

Prevalence of Phelan McDermid Syndrome Estimated To Be ~1:7300 Using a Multisource Model

Autism Research, EarlyView.
ABSTRACT Estimating the prevalence of genetic disorders is complicated by many factors including sampling bias and differing methods of estimation. However, establishing the true prevalence of these disorders is critical for understanding disease burden, pharmacoeconomic modeling, and resource allocation for testing and care.
Tess Levy, David Lapidus, Kate Friedman, Paige Siper, Larry Glass, Liza Squires, Mary Hames, Joseph D. Buxbaum, Genetic Testing Consortium, Brooklynn Gasser, Meghan Towne, Behrang Mahjani, Seulgi Jung, Stuart Schwartz, Kai Lee Yap, Mindy Li, Avinash V. Dharmadhikari, Gordana Raca, Dolores B. Estrine, Stefanie Biller, Amanda Singleton, Sarah Poll, Alexander Kolevzon   +22 more
wiley   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Non-Differentiable Loss Function Optimization and Interaction Effect Discovery in Insurance Pricing Using the Genetic Algorithm

Risks
Insurance pricing is the process of determining the premiums that policyholders pay in exchange for insurance coverage. In order to estimate premiums, actuaries use statistical based methods, assessing various factors such as the probability of certain ...
Robin Van Oirbeek, Félix Vandervorst, Thomas Bury, Gireg Willame, Christopher Grumiau, Tim Verdonck   +5 more
doaj   +1 more source